Brainstorm Cell Therapeutics  logo
Brainstorm Cell Therapeutics BCLI
$ 2.26 8.73%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Brainstorm Cell Therapeutics P/B Ratio 2011-2024 | BCLI

Annual P/B Ratio Brainstorm Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-6.56 -22.2 7.48 5.31 -7.2 14.7 11.5 5.18 3.22 8.17 15.9 7.95 17.8

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
17.8 -22.2 4.71